US Senator Warren (D) reportedly raises concerns over risks disclosed in Anthropic's IPO filings and is demanding answers to a series of questions ahead of its planned listing, WSJ reports citing sources

• Asks for answers by November 3rd.

Pre-IPO letters from senior senators are a familiar pattern: the lawmaker takes public issue with risk-factor disclosures, sets a short response deadline, and generates headlines well ahead of any actual enforcement lever. Historically these interventions have mattered most for timing and narrative rather than as a bar to listing, since a senator has no direct authority over an S-1; the SEC controls effectiveness, and congressional pressure has tended to influence outcomes only when it prompts the regulator to slow its review or demand expanded disclosure. The channel here is reputational and procedural, not legal: issuers in this position typically answer the letter, tighten risk language, and proceed, though the exchange becomes part of the diligence file that underwriters and anchor investors work through. Warren's prior form is consistent, serial letters to companies and regulators framed around consumer and systemic risk, rarely followed by legislation, but effective at raising the political cost of a deal. Worth noting is whether the questions target AI-specific exposures such as model safety, compute concentration, or revenue dependence, since that shapes which disclosures get renegotiated. The follow-ons that carry signal are any SEC comment-letter cadence on the filing, the company's formal reply by the stated deadline, and whether other lawmakers or committees attach themselves to the inquiry.